Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.66
-0.19 (-3.25%)
Jun 13, 2025, 4:00 PM - Market closed
Tenax Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tenax Therapeutics stock have an average target of 16, which predicts a 182.69% increase from the current stock price of 5.66.
Price Target: $16 (+182.69%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 24, 2024.
Analyst Ratings
The average analyst rating for Tenax Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +182.69% | Oct 24, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +182.69% | Oct 14, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 30, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +430.04% | Feb 20, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +8,380.57% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.10
from -1.15
EPS Next Year
-1.14
from -1.10
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | n/a | 27.1M | ||
Avg | n/a | n/a | 6.6M | ||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -0.93 | -0.99 | -0.93 | ||
Avg | -1.10 | -1.14 | -1.02 | ||
Low | -1.29 | -1.34 | -1.13 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.